Furthermore, overexpression of CHKα and CCT in GBM cells upregulated the expression of GFAP, which suggested that activation of the choline metabolic pathway drives the differentiation of GBM cells (Figure 4C-D). Here, FLVCR2 is linked to glioblastoma.